“We are very pleased to have Tim Nilsson on board. He has a highly relevant background; he holds a Master of Science in chemistry and is very socially competent as well as well experienced within marketing and sales. This makes him the perfect fit for the role as product specialist”, says Stefan Nilsson, CEO of Lumito.
Lumitos technology allows several tests to be made simultaneously on the same tissue section. An extensive tissue sample is quickly digitalized, and only the areas that contain the relevant tissue are imaged with higher resolution. The technology is much better suited for computer analysis than traditional immunohistochemical methods, since the image quality is so high. This results in more reliable diagnoses and faster response times.
The company is now preparing for the initial product launch on reference clinics.
“Lumito's product is very interesting – it can definitely make it easier for pathologists, not to mention its potential to reduce patients' concerns thanks to reduced time of analysis and more reliable responses. I look forward to joining the team as product specialist," says Tim Nilsson.
For additional information, please contact:
Stefan Nilsson, CEO of Lumito
E-mail: sn@lumito.se
Telephone: +4676-778 59 05
Lumito is specialised in research and development of imaging technologies for medical applications. The technology is based on so called UCNP:s (Up Converting Nano Particles) and is aiming to increase image quality in biomedical applications. Lumito´s IPR covers imaging with high quality of for instance tissue samples, with UCNP:s as markers. The technology has several possible application areas, but Lumito has initially decided to focus on digital pathology. Lumito’s share Lumito are traded at the NGM Nordic MTF marketplace.
